24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Testosterone regulates the expression and functional activity of sphingosine‐1‐phosphate receptors in the rat corpus cavernosum

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The bioactive lipid sphingosine‐1‐phosphate (S1P) regulates smooth muscle ( SM) contractility predominantly via three G protein‐coupled receptors. The S1P1 receptor is associated with nitric oxide ( NO)‐mediated SM relaxation, while S1P2 & S1P3 receptors are linked to SM contraction via activation of the Rho‐kinase pathway. This study is to determine testosterone (T) modulating the expression and functional activity of S1P receptors in corpus cavernosum ( CC). Adult male Sprague‐Dawley rats were randomly divided into three groups: sham‐operated controls, surgical castration and T supplemented group. Serum S1P levels were detected by high‐performance liquid chromatography. The expression of S1P1‐3 receptors and sphingosine kinases was detected by real‐time RTPCR. In vitro organ bath contractility and in vivo intracavernous pressure ( ICP) measurement were also performed. T deprivation significantly decreased ICP rise. Meanwhile, surgical castration induced a significant increase in serum S1P level and the expression of S1P2‐3 receptors by twofold ( <  0.05) but a decrease in the expression of S1P1 receptor. Castration also augmented exogenous phenylephrine ( PE), S1P, S1P1,3 receptor agonist FTY720‐P contractility and S1P2‐specific antagonist JTE013 relaxation effect. T supplemented could restore the aforementioned changes. We provide novel data that castration increased serum S1P concentration and up‐regulated the expression of S1P2‐3 receptors in CC. Consistently, agonizing S1P receptors induced CCSM contraction and antagonizing mediated relaxation were augmented. This provides the first clear evidence that S1P system dysregulation may contribute to hypogonadism‐related erectile dysfunction ( ED), and S1P receptors may be expected as a potential target for treating ED.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          Erythrocytes store and release sphingosine 1-phosphate in blood.

          The blood constituent sphingosine 1-phosphate (S1P) is a specific ligand for five G-protein-coupled receptors designated S1P(1-5). Expression of the S1P1 receptor on lymphocytes is required for their exit from secondary lymphoid organs, suggesting that S1P serves as a stimulus for maintaining lymphocyte circulation in blood. Despite its potential role in immune surveillance, the regulatory system that controls blood S1P levels is not well understood. This report reveals that erythrocytes constitute a buffer system for S1P in blood. They efficiently incorporated and stored S1P, and protected it from cellular degradation. They also released S1P into plasma, but not into other serum-free media, indicating that S1P release was controlled by a plasma factor. Erythrocytes did not generate S1P since an increase in plasma S1P levels was always accompanied by a decrease in cellular S1P levels. Thrombocytes that were reported to generate and release S1P after activation did not contribute to the observed S1P release in blood. The amount of erythrocytes as well as the proportion of plasma in the medium determined the magnitude of S1P release. Adoptively transferred S1P-loaded and unloaded mouse erythrocytes displayed a normal life span and similar S1P levels 24 h after recovery, indicating that S1P incorporation and release are dynamically regulated in vivo.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.

            FTY720, a potent immunomodulatory drug in phase 2/3 clinical trials, induces rapid and reversible sequestration of lymphocytes into secondary lymphoid organs, thereby preventing their migration to sites of inflammation. As prerequisite for its function, phosphorylation of FTY720 to yield a potent agonist of the sphingosine-1-phosphate receptor S1P(1) is required in vivo, catalyzed by an as-yet-unknown kinase. Here, we report on the generation of sphingosine kinase 2 (SPHK2) knockout mice and demonstrate that this enzyme is essential for FTY720 phosphate formation in vivo. Consequently, administration of FTY720 does not induce lymphopenia in SPHK2-deficient mice. After direct dosage of FTY720 phosphate, lymphopenia is only transient in this strain, indicating that SPHK2 is constantly required to maintain FTY720 phosphate levels in vivo.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Lysophospholipids--receptor revelations.

              Upon cell activation, membrane phospholipids are metabolized into potent lysophospholipid (LP) mediators, such as sphingosine 1-phosphate and lysophosphatidic acid. LPs fulfill signaling roles in organisms as diverse as yeast and humans. The recent discovery of G protein-coupled receptors for LPs in higher eukaryotes, and their involvement in regulating diverse processes such as angiogenesis, cardiac development, neuronal survival, and immunity, has stimulated growing interest in these lipid mediators. LP receptor biology has generated insights into fundamental cellular mechanisms and may provide therapeutic targets for drug development.
                Bookmark

                Author and article information

                Contributors
                zhangxinhuad@163.com
                Journal
                J Cell Mol Med
                J. Cell. Mol. Med
                10.1111/(ISSN)1582-4934
                JCMM
                Journal of Cellular and Molecular Medicine
                John Wiley and Sons Inc. (Hoboken )
                1582-1838
                1582-4934
                20 December 2017
                March 2018
                : 22
                : 3 ( doiID: 10.1111/jcmm.2018.22.issue-3 )
                : 1507-1516
                Affiliations
                [ 1 ] Department of Rehabilitation Zhongnan Hospital of Wuhan University Wuhan China
                [ 2 ] Department of Urology Zhongnan Hospital of Wuhan University Wuhan China
                [ 3 ] Surgery and Biomedical Sciences Cooper Medical School of Rowan University Camden NJ USA
                Author notes
                [*] [* ] Correspondence to: Dr. Xin‐hua ZHANG MD, Ph.D.

                E‐mail: zhangxinhuad@ 123456163.com

                [†]

                These authors contributed equally to this work.

                Author information
                http://orcid.org/0000-0003-0267-428X
                Article
                JCMM13416
                10.1111/jcmm.13416
                5824404
                29266713
                42eee942-78dc-4c48-8dbe-8ae77dcb4a2a
                © 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 25 December 2016
                : 12 September 2017
                Page count
                Figures: 9, Tables: 0, Pages: 10, Words: 6064
                Funding
                Funded by: National Natural Science Foundation of China
                Award ID: N.81270843
                Award ID: N.81160086
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                jcmm13416
                March 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.2.2 mode:remove_FC converted:23.02.2018

                Molecular medicine
                sphingosine‐1‐phosphate,testosterone,corpus cavernosum,smooth muscle,erectile dysfunction

                Comments

                Comment on this article